The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2022
Filed:
Nov. 04, 2019
Applicants:
Auckland Uniservices Limited, Auckland, NZ;
Ocunexus Therapeutics, Inc., San Diego, CA (US);
Inventors:
Colin Richard Green, Auckland, NZ;
Yeri Kim, Auckland, NZ;
Anthony Phillips, Auckland, NZ;
Bradford James Duft, Solana Beach, CA (US);
Assignees:
AUCKLAND UNISERVICES LIMITED, Auckland, NZ;
OCUNEXUS THERAPEUTICS, INC., San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/04 (2006.01); C12N 15/113 (2010.01); A61K 38/08 (2019.01); A61K 38/39 (2006.01); A61K 9/00 (2006.01); A61K 31/167 (2006.01); A61K 31/557 (2006.01); A61K 31/498 (2006.01); A61K 31/5575 (2006.01); A61K 31/195 (2006.01); A61K 31/382 (2006.01); A61K 31/575 (2006.01); A61K 31/5377 (2006.01); A61P 27/02 (2006.01); A61K 31/352 (2006.01); A61K 31/713 (2006.01); A61K 38/10 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 9/0048 (2013.01); A61K 31/167 (2013.01); A61K 31/195 (2013.01); A61K 31/352 (2013.01); A61K 31/382 (2013.01); A61K 31/498 (2013.01); A61K 31/5377 (2013.01); A61K 31/557 (2013.01); A61K 31/5575 (2013.01); A61K 31/575 (2013.01); A61K 31/713 (2013.01); A61K 38/08 (2013.01); A61K 38/10 (2013.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); C12N 15/1138 (2013.01); C12N 2310/11 (2013.01); C12N 2310/3231 (2013.01);
Abstract
The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.